159 related articles for article (PubMed ID: 24908283)
21. [Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].
Mauricio D
Med Clin (Barc); 2013 Sep; 141 Suppl 2():31-5. PubMed ID: 24444522
[TBL] [Abstract][Full Text] [Related]
22. Novel SLC5A2 variants contribute to renal glucosuria in Chinese families: abnormal expression and dysfunction of variant SLC5A2.
Yu L; Hou P; Lv JC; Liu GP; Zhang H
Hum Mutat; 2015 Jan; 36(1):79-86. PubMed ID: 25339128
[TBL] [Abstract][Full Text] [Related]
23. Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion.
Calado J; Sznajer Y; Metzger D; Rita A; Hogan MC; Kattamis A; Scharf M; Tasic V; Greil J; Brinkert F; Kemper MJ; Santer R
Nephrol Dial Transplant; 2008 Dec; 23(12):3874-9. PubMed ID: 18622023
[TBL] [Abstract][Full Text] [Related]
24. Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria.
Calado J; Soto K; Clemente C; Correia P; Rueff J
Hum Genet; 2004 Feb; 114(3):314-6. PubMed ID: 14614622
[TBL] [Abstract][Full Text] [Related]
25. MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.
Coady MJ; El Tarazi A; Santer R; Bissonnette P; Sasseville LJ; Calado J; Lussier Y; Dumayne C; Bichet DG; Lapointe JY
J Am Soc Nephrol; 2017 Jan; 28(1):85-93. PubMed ID: 27288013
[TBL] [Abstract][Full Text] [Related]
26. Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.
Santer R; Calado J
Clin J Am Soc Nephrol; 2010 Jan; 5(1):133-41. PubMed ID: 19965550
[TBL] [Abstract][Full Text] [Related]
27. Familial renal glycosuria and modifications of glucose renal excretion.
Prié D
Diabetes Metab; 2014 Dec; 40(6 Suppl 1):S12-6. PubMed ID: 25554066
[TBL] [Abstract][Full Text] [Related]
28. Performance of the ACMG-AMP criteria in a large familial renal glucosuria cohort with identified SLC5A2 sequence variants.
Barata R; Fila M; Dalla-Vale F; Bogarin R; Nunes P; Ramalho J; Rueff J; Calado J
Clin Genet; 2023 Nov; 104(5):582-586. PubMed ID: 37349938
[TBL] [Abstract][Full Text] [Related]
29. Persistently high urine glucose levels caused by familial renal glycosuria.
Djeddi D; Cauliez A; Oulebsir A; Hureaux M; Vanrenterghem A; Vargas-Poussou R
Arch Pediatr; 2020 Oct; 27(7):386-387. PubMed ID: 32807621
[TBL] [Abstract][Full Text] [Related]
30. Acquired renal glucosuria in an undifferentiated connective tissue disease patient with a SLC5A2 heterozygous mutation: A case report.
Gu X; Chen M; Xu Y; Wang Y
Medicine (Baltimore); 2018 Dec; 97(50):e13664. PubMed ID: 30558067
[TBL] [Abstract][Full Text] [Related]
31. Renal glucosuria is associated with lower body weight and lower rates of elevated systolic blood pressure: results of a nationwide cross-sectional study of 2.5 million adolescents.
Fishman B; Shlomai G; Twig G; Derazne E; Tenenbaum A; Fisman EZ; Leiba A; Grossman E
Cardiovasc Diabetol; 2019 Sep; 18(1):124. PubMed ID: 31554505
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria.
Gong S; Guo J; Han X; Li M; Zhou L; Cai X; Zhu Y; Luo Y; Zhang S; Zhou X; Ma Y; Ji L
J Clin Endocrinol Metab; 2017 May; 102(5):1548-1556. PubMed ID: 28324025
[TBL] [Abstract][Full Text] [Related]
33. A young-onset type 2 diabetic Chinese girl with familial renal glycosuria caused by a novel mutation in SLC5A2: A case report.
Qu Y; Hao L; Wang X
J Diabetes; 2023 Jul; 15(7):622-626. PubMed ID: 37193603
[No Abstract] [Full Text] [Related]
34. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.
Solini A; Rossi C; Mazzanti CM; Proietti A; Koepsell H; Ferrannini E
Diabetes Obes Metab; 2017 Sep; 19(9):1289-1294. PubMed ID: 28419670
[TBL] [Abstract][Full Text] [Related]
35. Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10.
Unno K; Yamamoto H; Toda M; Hagiwara S; Iguchi K; Hoshino M; Takabayashi F; Hasegawa-Ishii S; Shimada A; Hosokawa M; Higuchi K; Mori M
Biochem Biophys Res Commun; 2014 Nov; 454(1):89-94. PubMed ID: 25450362
[TBL] [Abstract][Full Text] [Related]
36. Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
Ellsworth BA; Meng W; Patel M; Girotra RN; Wu G; Sher PM; Hagan DL; Obermeier MT; Humphreys WG; Robertson JG; Wang A; Han S; Waldron TL; Morgan NN; Whaley JM; Washburn WN
Bioorg Med Chem Lett; 2008 Sep; 18(17):4770-3. PubMed ID: 18707880
[TBL] [Abstract][Full Text] [Related]
37. Clinical features of pediatric renal glucosuria cases due to SLC5A2 gene variants.
Dorum S; Erdoğan H; Köksoy AY; Topak A; Görükmez Ö
Pediatr Int; 2022 Jan; 64(1):e14948. PubMed ID: 34380181
[TBL] [Abstract][Full Text] [Related]
38. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.
Abdul-Ghani MA; Norton L; Defronzo RA
Endocr Rev; 2011 Aug; 32(4):515-31. PubMed ID: 21606218
[TBL] [Abstract][Full Text] [Related]
39. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292
[TBL] [Abstract][Full Text] [Related]
40. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
